EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

G protein‐coupled receptor‐mediated signaling of immunomodulation in tumor progression

Guang-Hong Qiu iD, Bin Yu iD, Mei Ma iD

The FASEB Journal · 31.07.2024 · 38 (14)

DOI: 10.1096/fj.202400458r ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The FASEB Journal, online erschienen am 17.07.2024. Verfasst von Guang-Hong Qiu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, PR China. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Neoplasms, Signal Transduction, Immunotherapy. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Natural Science Foundation of Jiangxi Province (Jiangxi Natural Science Foundation), National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

G protein‐coupled receptors (GPCRs) are essential contributors to tumor growth and metastasis due to their roles in immune cell regulation. Therefore, GPCRs are potential targets for cancer immunotherapy. Here, we discuss the current understanding of the roles of GPCRs and their signaling pathways in tumor progression from an immunocellular perspective. Additionally, we focus on the roles of GPCRs in regulating immune checkpoint proteins involved in immune evasion. Finally, we review the progress of clinical trials of GPCR‐targeted drugs for cancer treatment, which may be combined with immunotherapy to improve treatment efficacy. This expanded understanding of the role of GPCRs may shed light on the mechanisms underlying tumor progression and provide a novel perspective on cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, G-Protein-CoupledNeoplasmsSignal TransductionImmunotherapyImmunomodulationHumansAnimalsDisease Progression

Stichwörter der Autor:innen

GPCRscancer immune checkpointscancer immunotherapyimmune cellstumor microenvironment

Substanzen

Receptors, G-Protein-Coupled

Autor:innen und Institutionen

  • Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, PR China.
  • Department of General Surgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, PR China.

ORCID-Profile: Guang-Hong Qiu, Bin Yu, Mei Ma

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • Natural Science Foundation of Jiangxi Province (Jiangxi Natural Science Foundation)
  • National Natural Science Foundation of China

Zitieren

APA

Qiu, G. H., Yu, B., & Ma, M. (2024). G protein‐coupled receptor‐mediated signaling of immunomodulation in tumor progression. The FASEB Journal, 38(14). https://doi.org/10.1096/fj.202400458r

Vancouver

Qiu GH, Yu B, Ma M. G protein‐coupled receptor‐mediated signaling of immunomodulation in tumor progression. The FASEB Journal. 2024;38(14). doi:10.1096/fj.202400458r

BibTeX
@article{Qiu2024,
  author = {Qiu, Guang-Hong and Yu, Bin and Ma, Mei},
  title = {G protein‐coupled receptor‐mediated signaling of immunomodulation in tumor progression},
  journal = {The FASEB Journal},
  year = {2024},
  volume = {38},
  number = {14},
  doi = {10.1096/fj.202400458r}
}
Kostenlos starten →